Breaking News

A health care inflection point?

December 8, 2024
avatar-torie-bosch
First Opinion editor

On Wednesday morning, we got the news: The CEO of United Healthcare had been shot in Manhattan. The public response was equally swift, and alarming: Some celebrated, turning the shooter into a folk hero; others were more measured, condemning the violence but saying that they understood why it had happened.

This response fascinated me. I wanted an expert to unpack it for me.

Of course, most of the people I reached out to declined. And I get it: It's a developing story — the motive may not be what everyone is assuming — and emotions are high. Professional researchers are cautious and want to wait for all the facts before weighing in, particularly on such a sensitive topic. (If I reached out to you, I hope you'll get back to me once you feel comfortable writing.)

But I was thrilled that Elliott S. Fisher of Dartmouth, who has written previously on greed in the health insurance industry, agreed to write. In an essay published Thursday night, he writes that some public rage against a broken system is understandable. "We let it happen," he writes. "By 'we,' I don't mean patients or the small businesses struggling to provide insurance for their employees. I mean the large organizations (businesses, universities) that have tried to cut a better deal for themselves while failing to see the larger system. I mean those of us working in health policy who have watched spending rise inexorably on our watch without questioning our assumptions. I mean myself. I was not paying attention while health care premiums in Vermont skyrocketed."

There will be much more on this story to come from First Opinion. As always, if you have ideas for essays or questions about the section, email me: first.opinion@statnews.com.

Recommendation of the week: I've been listening to the podcast "Ghost Church," about the early and modern days of American Spiritualism hosted by Jaime Loftus. It's sharply funny and balances skepticism with respect for her subject, a difficult balancing act. (And if you like "Ghost Church," check out the documentary "No One Dies in Lily Dale.")

Ron Batzdorff/NBC

Dr. Glaucomflecken says NBC's 'St. Denis Medical' makes medicine funny again

Will Flanary, aka YouTube star Dr. Dr. Glaucomflecken, on why medicine can be hilarious, and why patients can't be the butt of the joke in medical comedy.

By Will Flanary


Insurance companies like United Healthcare are not the only ones to blame for a broken system

The murder of United Healthcare CEO Brian Thompson horrified me. But I am not surprised by those who saw his death differently.

By Elliott S. Fisher


STAT+ | The invisible wasteland of health care data

The health care community must take substantive steps toward preventing the environmental damage caused by massive data storage and management.

By Ashten Duncan, Khuzeman Abbasi, and Sana Augustine



Adobe

STAT+ | Is this the beginning of the AI-in-drug-discovery era, or the beginning of the end?

If what's past is prologue, then investors may follow disillusioned founders and leave the nexus of AI and drug discovery altogether.

By Caleb Appleton


STAT+ | AI scribes are mostly rescuing doctors from themselves

AI scribes to take notes may seem like a life raft for clinicians, but why are they needed in the first place?

By Jeffrey Millstein


ADHD is this scientist's 'superpower'

Jeff Karp's elementary school teachers called him "a lost cause." Now he leads a revolutionary laboratory.

By Torie Bosch


DANIEL SLIM/AFP via Getty Images

STAT+ | Congress' critical opportunity to reshape health care

The bipartisan Lower Costs, More Transparency Act and Health Care PRICE Transparency Act 2.0 can lay the groundwork for future reforms.

By Jared Perkins and Chris Whaley


PulseNet identifies and stops foodborne illness outbreaks. Health care needs something similar

Genomic surveillance has proven its value in identifying outbreaks of foodborne illness. Let's use it to track infections in health care.

By Alexander Sundermann


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying First Opinion? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2024, All Rights Reserved.

No comments